Hussman Strategic Advisors, Inc. Celldex Therapeutics, Inc. Transaction History

Hussman Strategic Advisors, Inc.

  • $320 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 03, 2021
SELL
$16.19 - $29.91 $412,845 - $762,705
-25,500 Closed
0 $0
Q4 2020

Feb 01, 2021
SELL
$14.99 - $22.75 $382,245 - $580,125
-25,500 Reduced 50.0%
25,500 $447,000
Q3 2020

Nov 02, 2020
BUY
$9.65 - $15.19 $492,150 - $774,690
51,000 New
51,000 $756,000

Others Institutions Holding CLDX

# of Institutions
197
Shares Held
69.7M
Call Options Held
960K
Put Options Held
675K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $930M
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Hussman Strategic Advisors, Inc. Portfolio

Follow Hussman Strategic Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email